Chinese english Germany Japanese Korea

SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A) Mutated Peptide

SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A) Mutated Peptide Struktur
CAS-Nr.
Englisch Name:
SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A) Mutated Peptide
Synonyma:
SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A) Mutated Peptide
CBNumber:
CB513701551
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file
Request For Quotation

SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A) Mutated Peptide Eigenschaften

Sicherheit

SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A) Mutated Peptide Chemische Eigenschaften,Einsatz,Produktion Methoden

SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A) Mutated Peptide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A) Mutated Peptide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Beijing Boorsen Biotechnology Co., Ltd 400-901-9800 18611424007
 cis@bioss.com.cn China 9518 58
  • SARS-CoV-2 (2019-nCoV) Spike S1+S2 ECD (R683A, R685A) Mutated Peptide
Copyright 2019 © ChemicalBook. All rights reserved